drugset / Trial / NCT05871905

[14 C] Study on Mass Balance of TY-9591 in Healthy Chinese Subjects

NCT05871905

Phase 1 Completed 6 enrolled TYK Medicines, Inc
NaSingle-groupOpen-labelTreatment

Summary

\[14 C\] Mass balance clinical trial of TY-9591 in healthy Chinese subjects

Timeline

Start
2023-06-19
Primary completion
2023-11-06
Completion
2024-06-20

Drugs

EvaluationDrugModalityDoseRoute
Subject TY-9591 Unknown

Indications

No indication recorded.